Sensyne Health plc announces a strategic partnership with RwHealth for "SENSIGHT" Sensyne's real world data analytics platform. The agreement includes subscriptions for ten SENSIGHT seats initially. As part of this agreement, RwHealth will also become a "SENSIGHT Channel Partner" with the right to offer SENSIGHT to its customers. London headquartered RwHealth, is a healthcare and life sciences data company providing healthcare analytics and information services to UK and international health systems. By deploying advanced Artificial Intelligence and Machine Learning technology, RwHealth is able to leverage information at a local, national and global level to create real-time and predictive analytics for healthcare and life sciences. SENSIGHT is a clinical AI platform that provides industrial scale access to insights from anonymised and de-identified RWD, across multiple therapy areas, from Sensyne's partner healthcare organizations in the UK and US, combined with built-in simple to use research algorithms. The platform provides life science professionals, medical research academics and clinicians with instant access to AI research capability to analyse health insights to inform decision making, generate deeper insights into patient journeys and improve the speed and outcomes of clinical trials.